Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vasta Platform Ltd VSTA

Consumer Defensive Education & Training Services
Vasta Platform Ltd, is a company located in Brazil. The Company is dedicated to education. The service offers Digital platform as a service (PaaS). Its segments include Content & EdTech Platform and Digital Platform.


NDAQ:VSTA - Post by User

Vasta Platform Ltd
<< Previous
 Bullboard Posts
User Avatar Image
(227)
•••
Post by whytestockson Jul 09, 2024 3:45pm
58 Views
Post# 36124990

Vistagen Broadens PH80 Global Intellectual Property Portfoli

Vistagen Broadens PH80 Global Intellectual Property Portfoli
Breaking News: $VTGN Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of MigraineVistagen (Nasdaq: VTGN), a clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on nose-to-brain neurocircuitry, today announced the broadening of its global in...VTGN - Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine

<< Previous
 Bullboard Posts
Dealroom for high-potential pre-IPO opportunities